Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience

摘要

BackgroundPatients with cardiogenic shock (CS) are routinely treated with intra-aortic balloon pumps (IABPs). The utility of 2 new percutaneous left ventricular assist devices (PLVADs), the Impella and TandemHeart, is unknown. The objective of this study was to describe the use of PLVADs for patients with CS at our institution.